FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H229
K Number: K011920
·
Decision Jul 2, 2001
Classifications
1
FEI Numbers
23
Registration Numbers
23
Same Product Code
84
Applicant Total
19
Review Days
12
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H229
- K Number
- K011920
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 862.3320
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Syva Co., Dade Behring, Inc.
- Date Received
- June 20, 2001
- Decision Date
- July 2, 2001
- Product Code
- KXT
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| KXT | Enzyme Immunoassay, Digoxin | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (KXT), ordered by most recent decision date.
ADVIA Centaur® Digoxin assay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II
FDA 510(k)
FDA Class 2
·Clinical Toxicology
RANDOX DIGOXIN ASSAY
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DIMENSION VISTA LOCI DIGOXIN FLEX REAGENT CARTRIDGE (DIGXN), MODEL K6435
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ARCHITECT IDIGOXIN AND ARCHITECT IDIGOXIN CALIBRATORS, MODELS 1P32-25 AND IP32-01
FDA 510(k)
FDA Class 2
·Clinical Toxicology
AXSYM DIGOXIN III
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Syva Co., Dade Behring, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K011620 | EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229 | Jun 18, 2001 | Substantially Equivalent |
| K011605 | EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q229 | Jun 12, 2001 | Substantially Equivalent |
| K011300 | EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N229 | May 17, 2001 | Substantially Equivalent |
| K011306 | EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229 | May 16, 2001 | Substantially Equivalent |
| K011161 | MODIFICATION TO THE EMIT II PLUS PHENCYCLIDINE ASSAY, MODEL OSR9J229 | May 15, 2001 | Substantially Equivalent |
| K011289 | EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229 | May 15, 2001 | Substantially Equivalent |
| K011163 | MODIFICATION TO THE EMIT II PLUS PROPOXYPHENE ASSAY, MODEL OSR9G229 | May 10, 2001 | Substantially Equivalent |
| K011166 | MODIFICATION TO EMIT 2000 THEOPHYLLINE ASSAY, MODEL OSR 4P229 | May 10, 2001 | Substantially Equivalent |
| K011164 | MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229 | May 10, 2001 | Substantially Equivalent |
| K011162 | MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAY | May 2, 2001 | Substantially Equivalent |